NCT06063200View on ClinicalTrials.gov

Methylphenidate and Response to Alcohol Cues

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

March 20, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2025

Conditions
Alcohol Use DisorderAttention Deficit Hyperactivity Disorder
Interventions
DRUG

Methylphenidate Pill

Single encapsulated pill

Trial Locations (1)

32610

University of Florida, Gainesville

All Listed Sponsors
lead

University of Florida

OTHER

NCT06063200 - Methylphenidate and Response to Alcohol Cues | Biotech Hunter | Biotech Hunter